Your browser doesn't support javascript.
Microbiota regulation of viral infections through interferon signaling.
Wirusanti, Nurul I; Baldridge, Megan T; Harris, Vanessa C.
  • Wirusanti NI; Department of Global Health - Amsterdam Institute for Global Health and Development (AIGHD), Amsterdam University Medical Center, Academic Medical Center, Amsterdam, The Netherlands; Division of Infectious Diseases and Center for Experimental and Molecular Medicine (CEMM), Department of Medicine, Amsterdam University Medical Center, Academic Medical Center, Amsterdam, The Netherlands.
  • Baldridge MT; Division of Infectious Diseases, Department of Medicine, Edison Family Center for Genome Sciences & Systems Biology, Washington University School of Medicine, St Louis, MO, USA; Department of Molecular Microbiology, Washington University School of Medicine, St Louis, MO, USA.
  • Harris VC; Department of Global Health - Amsterdam Institute for Global Health and Development (AIGHD), Amsterdam University Medical Center, Academic Medical Center, Amsterdam, The Netherlands; Division of Infectious Diseases and Center for Experimental and Molecular Medicine (CEMM), Department of Medicine, Amsterdam University Medical Center, Academic Medical Center, Amsterdam, The Netherlands. Electronic address: v.c.harris@amsterdamumc.nl.
Trends Microbiol ; 30(8): 778-792, 2022 08.
Article in English | MEDLINE | ID: covidwho-1663909
ABSTRACT
The interferon (IFN) response is the major early innate immune response against invading viral pathogens and is even capable of mediating sterilizing antiviral immunity without the support of the adaptive immune system. Cumulative evidence suggests that the gut microbiota can modulate IFN responses, indirectly determining virological outcomes. This review outlines our current knowledge of the interactions between the gut microbiota and IFN responses and dissects the different mechanisms by which the gut microbiota may alter IFN expression to diverse viral infections. This knowledge offers a basis for translating experimental evidence from animal studies into the human context and identifies avenues for leveraging the gut microbiota-IFN-virus axis to improve control of viral infections and performance of viral vaccines.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Virus Diseases / Microbiota Topics: Vaccines Limits: Animals / Humans Language: English Journal: Trends Microbiol Journal subject: Microbiology Year: 2022 Document Type: Article Affiliation country: J.tim.2022.01.007

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Virus Diseases / Microbiota Topics: Vaccines Limits: Animals / Humans Language: English Journal: Trends Microbiol Journal subject: Microbiology Year: 2022 Document Type: Article Affiliation country: J.tim.2022.01.007